SCHEMBL1389695

SCHEMBL1389695

Cc1ccccc1[C@H](CC(Cc1ccncc1)=NO)c1ccc(-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.60
SRD5A2 P31213 1/20 0.39
MMP13 P45452 1/20 0.37
NR3C2 P08235 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
RPS6KA5 O75582 5/20 0.36
AKT1 P31749 5/20 0.36
GSK3B P49841 5/20 0.36
PRKCD Q05655 5/20 0.36
PRKG2 Q13237 5/20 0.36
ROCK1 Q13464 5/20 0.36
PRKG1 Q13976 5/20 0.36
PKN2 Q16513 5/20 0.36
CLK4 Q9HAZ1 5/20 0.36
ROCK2 O75116 4/20 0.36
MAP4K4 O95819 4/20 0.36
RPS6KB1 P23443 4/20 0.36
MAPK1 P28482 4/20 0.36
GSK3A P49840 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL363855 1.00 GPBAR1 (0.60) GPBAR1SRD5A2MMP13NR3C2GAA
SCHEMBL1389694 1.00 GPBAR1 (0.60) GPBAR1SRD5A2MMP13NR3C2GAA
SCHEMBL364346 1.00 GPBAR1 (0.60) GPBAR1SRD5A2MMP13NR3C2GAA
SCHEMBL1389692 1.00 GPBAR1 (0.60) GPBAR1SRD5A2MMP13NR3C2GAA
SCHEMBL15949123 0.87 GPBAR1 (0.46) GPBAR1NR3C2MAPTMEN1KMT2A
SCHEMBL362261 0.84 GPBAR1 (0.50) GPBAR1NR3C2GAAMAPTKMT2A
SCHEMBL363993 0.84 GPBAR1 (0.50) GPBAR1NR3C2GAAMAPTKMT2A
SCHEMBL362259 0.84 GPBAR1 (0.50) GPBAR1NR3C2GAAMAPTKMT2A
SCHEMBL15959004 0.84 GPBAR1 (0.40) GPBAR1NR3C2GAAMAPTMAPK1
SCHEMBL362260 0.84 GPBAR1 (0.50) GPBAR1NR3C2GAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885SRD5A2 735/4885MMP13 4163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.